Literature DB >> 22681126

Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles.

Yingchao Han1, Zhijian He, Anita Schulz, Tatiana K Bronich, Rainer Jordan, Robert Luxenhofer, Alexander V Kabanov.   

Abstract

Many effective drugs for cancer treatment are poorly water-soluble. In combination chemotherapy, needed excipients in additive formulations are often toxic and restrict their applications in clinical intervention. Here, we report on amphiphilic poly(2-oxazoline)s (POx) micelles as a promising high capacity delivery platform for multidrug cancer chemotherapy. A variety of binary and ternary drugs combinations of paclitaxel (PTX), docetaxel (DTX), 17-allylamino-17-demethoxygeldanamycin (17-AAG), etoposide (ETO) and bortezomib (BTZ) were solubilized in defined polymeric micelles achieving unprecedented high total loading capacities of up to 50 wt % drug per final formulation. Multidrug loaded POx micelles showed enhanced stability in comparison to single-drug loaded micelles. Drug ratio dependent synergistic cytotoxicity of micellar ETO/17-AAG was observed in MCF-7 cancer cells and of micellar BTZ/17-AAG in MCF-7, PC3, MDA-MB-231 and HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681126      PMCID: PMC3534837          DOI: 10.1021/mp300159u

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  41 in total

Review 1.  The proteasome: a suitable antineoplastic target.

Authors:  Julian Adams
Journal:  Nat Rev Cancer       Date:  2004-05       Impact factor: 60.716

2.  The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting.

Authors:  A V Kabanov; V P Chekhonin; E V Batrakova; A S Lebedev; N S Melik-Nubarov; S A Arzhakov; A V Levashov; G V Morozov; E S Severin
Journal:  FEBS Lett       Date:  1989-12-04       Impact factor: 4.124

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

5.  Polyoxazoline: chemistry, properties, and applications in drug delivery.

Authors:  Tacey X Viegas; Michael D Bentley; J Milton Harris; Zhihao Fang; Kunsang Yoon; Bekir Dizman; Rebecca Weimer; Anna Mero; Gianfranco Pasut; Francesco M Veronese
Journal:  Bioconjug Chem       Date:  2011-04-20       Impact factor: 4.774

6.  Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.

Authors:  D M Nguyen; D Lorang; G A Chen; J H Stewart; E Tabibi; D S Schrump
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

7.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

8.  Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.

Authors:  Edward G Mimnaugh; Wanping Xu; Michele Vos; Xitong Yuan; Jennifer S Isaacs; Kheem S Bisht; David Gius; Len Neckers
Journal:  Mol Cancer Ther       Date:  2004-05       Impact factor: 6.261

Review 9.  The dawning era of polymer therapeutics.

Authors:  Ruth Duncan
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

10.  Hypersensitivity reactions from taxol.

Authors:  R B Weiss; R C Donehower; P H Wiernik; T Ohnuma; R J Gralla; D L Trump; J R Baker; D A Van Echo; D D Von Hoff; B Leyland-Jones
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

View more
  37 in total

1.  Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.

Authors:  Lei Miao; Shutao Guo; Jing Zhang; William Y Kim; Leaf Huang
Journal:  Adv Funct Mater       Date:  2014-11-12       Impact factor: 18.808

2.  Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.

Authors:  Zhijian He; Anita Schulz; Xiaomeng Wan; Joshua Seitz; Herdis Bludau; Daria Y Alakhova; David B Darr; Charles M Perou; Rainer Jordan; Iwao Ojima; Alexander V Kabanov; Robert Luxenhofer
Journal:  J Control Release       Date:  2015-02-26       Impact factor: 9.776

3.  Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.

Authors:  Swapnil S Desale; Srikumar M Raja; Jong Oh Kim; Bhopal Mohapatra; Kruti S Soni; Haitao Luan; Stetson H Williams; Timothy A Bielecki; Dan Feng; Matthew Storck; Vimla Band; Samuel M Cohen; Hamid Band; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-02-03       Impact factor: 9.776

Review 4.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

5.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

6.  Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

Authors:  Gaurav Bharadwaj; Viet Nhan; ShanChao Yang; Xiaocen Li; Anand Narayanan; Ana Carolina Macarenco; Yu Shi; Darrion Yang; Letícia Salvador Vieira; Wenwu Xiao; Yuanpei Li; Kit S Lam
Journal:  Nanomedicine (Lond)       Date:  2017-04-27       Impact factor: 5.307

7.  Maleimide-Functionalized Poly(2-Oxazoline)s and Their Conjugation to Elastin-Like Polypeptides.

Authors:  Jonas F Nawroth; Jonathan R McDaniel; Ashutosh Chilkoti; Rainer Jordan; Robert Luxenhofer
Journal:  Macromol Biosci       Date:  2016-01-12       Impact factor: 4.979

8.  Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.

Authors:  Jing Zhang; Lei Miao; Shutao Guo; Yuan Zhang; Lu Zhang; Andrew Satterlee; William Y Kim; Leaf Huang
Journal:  J Control Release       Date:  2014-03-15       Impact factor: 9.776

Review 9.  Nanocarriers for delivery of platinum anticancer drugs.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Alexander V Kabanov; Tatiana K Bronich
Journal:  Adv Drug Deliv Rev       Date:  2013-10-08       Impact factor: 15.470

Review 10.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.